Metraipolis › archive › dc_e105ecfe29d7

Leucine rich amelogenin peptide prevents ovariectomy-induced bone loss in mice — Europe PMC PMID:34780561

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/34780561
DOI
10.1371/journal.pone.0259966
License (as archived)
CC0-1.0
Archived
2026-10-10T00:53:18.357Z
SHA-256 of the archived text
a4819b9f6a6a9104b940f0b923920ae8eda3ee0324c11d6794ad3a9800e1c1ac
Stable URL of this page
https://metraipolis.com/documento/dc_e105ecfe29d7

How to cite

Leucine rich amelogenin peptide prevents ovariectomy-induced bone loss in mice — Europe PMC PMID:34780561 — Europe PMC (en), https://europepmc.org/article/MED/34780561 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_e105ecfe29d7 (Metraipolis archive dc_e105ecfe29d7, sha256 a4819b9f6a6a9104b940f0b923920ae8eda3ee0324c11d6794ad3a9800e1c1ac)
BibTeX
@misc{dce105ecfe29d7,
  title = {Leucine rich amelogenin peptide prevents ovariectomy-induced bone loss in mice — Europe PMC PMID:34780561},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/34780561},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_e105ecfe29d7; sha256 a4819b9f6a6a9104b940f0b923920ae8eda3ee0324c11d6794ad3a9800e1c1ac},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/34780561. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Amelogenins, major extra cellular matrix proteins of developing tooth enamel, are predominantly expressed by ameloblasts and play significant roles in the formation of enamel. Recently, amelogenin has been detected in various epithelial and mesenchymal tissues, implicating that it might have distinct functions in various tissues. We have previously reported that leucine rich amelogenin peptide (LRAP), one of the alternate splice forms of amelogenin, regulates receptor activator of NF-kappa B ligand (RANKL) expression in cementoblast/periodontal ligament cells, suggesting that the amelogenins, especially LRAP, might function as a signaling molecule in bone metabolism. The objective of this study was to identify and define LRAP functions in bone turnover. We engineered transgenic (TgLRAP) mice using a murine 2.3kb α1(I)-collagen promoter to drive expression of a transgene consisting of LRAP, an internal ribosome entry site (IRES) and enhanced green fluorescent protein (EGFP) to study functions of LRAP in bone formation and resorption. Calvarial cell cultures from the TgLRAP mice showed increased alkaline phosphatase (ALP) activity and increased formation of mineralized nodules compared to the cells derived from wild-type (WT) mice. The TgLRAP calvarial cells also showed an inhibitory effect on osteoclastogenesis in vitro. Gene expression comparison by quantitative polymerase chain reaction (Q-PCR) in calvarial cells indicated that bone formation makers such as Runx2, Alp, and osteocalcin were increased in TgLRAP compared to the WT cells. Meanwhile, Rankl expression was decreased in the TgLRAP cells in vitro. The ovariectomized (OVX) TgLRAP mice resisted bone loss induced by ovariectomy resulting in higher bone mineral density in comparison to OVX WT mice. The quantitative analysis of calcein intakes indicated that the ovariectomy resulted in increased bone formation in both WT and TgLRAP mice; OVX TgLRAP appeared to show the most remarkably increased bone formation. The parameters for bone resorption in tissue sections showed increased number of osteoclasts in OVX WT, but not in OVX TgLRAP over that of sham operated WT or TgLRAP mice, supporting the observed bone phenotypes in OVX mice. This is the first report identifying that LRAP, one of the amelogenin splice variants, affects bone turnover in vivo.

Tema degli esploratori: diritto e tecnologia (ricerca Europe PMC «Creative Commons license», solo open access).
Pubblicazione: PloS one, 2021 (prima pubblicazione 2021-11-15).
Identificativi: PMID 34780561 · PMCID PMC8592471 · DOI 10.1371/journal.pone.0259966.
Pagina: https://europepmc.org/article/MED/34780561 — https://doi.org/10.1371/journal.pone.0259966. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-09T23:33:54.275Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.